-Hikaru Koide Researcher Activity Profile

Research Author Detailed Information 

Hikaru Koide Publication Rate By Year

Hikaru Koide has published 1 paper(s) in 1971, 16 paper(s) in 2007, for a total of 17 research publications in total.

Hikaru H Koide Author Information

LAST NAME: koide

FIRST NAME: Hikaru

INITIALS: h

AFFILIATION:

Papers

Hikaru Koide's Publication Record

1. Evaluation of the heart and great vessel calcification by conventional computed tomography in hemodialysis patients. Year Published: 2007
Department of Cardiology, Koto Hospital. Tokyo. Japan.
2. Urinary excretion of creatol, an in vivo biomarker of hydroxyl radical, in patients with chronic renal failure. Year Published: 2007
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co., Ltd, Hyogo, Japan.
3. Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Year Published: 2007
Department of Pathological Oncology, Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Japan.
4. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy. Year Published: 2007
Department of Medicine, Shinmatsudo Central General Hospital, Matsudo, Japan.
5. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock. Year Published: 2007
Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan.
6. The effects of cations on the inhibition of K plus-activated phosphatase by beryllium. Year Published: 1971
7. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock. Year Published: 2007
Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan.
8. Enhancement of antitumor activity of OK-432 (Picibanil) by Triton X-114 phase partitioning. Year Published: 2007
Department of Nanostructure and Advanced Materials, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto, Kagoshima 890-0065, Japan.
9. Intravascular ultrasound assessment of atherosclerotic plaque in the aorta. Year Published: 2007
Department of Cardiology, Koto Hospital, 6-8-5 Ojima Koto-ku, Tokyo, Japan.
10. Intravascular ultrasound assessment of atherosclerotic plaque in the aorta. Year Published: 2007
Department of Cardiology, Koto Hospital, 6-8-5 Ojima Koto-ku, Tokyo, Japan. tamiya.812@krd.biglobe.ne.jp
11. Enhancement of antitumor activity of OK-432 (Picibanil) by Triton X-114 phase partitioning. Year Published: 2007
Department of Nanostructure and Advanced Materials, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto, Kagoshima 890-0065, Japan.
12. Enhancement of antitumor activity of OK-432 (Picibanil) by Triton X-114 phase partitioning. Year Published: 2007
Department of Nanostructure and Advanced Materials, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto, Kagoshima 890-0065, Japan.
13. Intravascular ultrasound assessment of atherosclerotic plaque in the aorta. Year Published: 2007
Department of Cardiology, Koto Hospital, 6-8-5 Ojima Koto-ku, Tokyo, Japan. tamiya.812@krd.biglobe.ne.jp
14. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy. Year Published: 2007
Department of Medicine, Shinmatsudo Central General Hospital, Matsudo, Japan.
15. Enhancement of antitumor activity of OK-432 (picibanil) by Triton X-114 phase partitioning. Year Published: 2007
Department of Nanostructure and Advanced Materials, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto, Kagoshima 890-0065, Japan.
16. Evaluation of the heart and great vessel calcification by conventional computed tomography in hemodialysis patients. Year Published: 2007
Department of Cardiology, Koto Hospital, Tokyo, Japan.
17. Urinary excretion of creatol, an in vivo biomarker of hydroxyl radical, in patients with chronic renal failure. Year Published: 2007
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co., Ltd, Hyogo, Japan.